Sudo Biosciences

Last updated: July 30, 2024

CEO - Scott Byrd
CEO - Scott Byrd
USA | Funding: $183M (+)

Website: https://www.sudobio.com

Sudo Biosciences is a biopharmaceutical company committed to developing cutting-edge medications that are unmatched in their class that advances programs in multiple sclerosis and psoriasis